You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 128 No. 4, April 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (15)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Sleep Apnea
 •Alert me on articles by topic

Usefulness of Uvulopalatopharyngoplasty With Genioglossus and Hyoid Advancement in the Treatment of Obstructive Sleep Apnea

Isabel Vilaseca, MD; Antonio Morelló, MD; Josep María Montserrat, MD; Joan Santamaría, MD; Alex Iranzo, MD

Arch Otolaryngol Head Neck Surg. 2002;128:435-440.

Objective  To evaluate the usefulness of uvulopalatopharyngoplasty plus mandibular osteotomy with genioglossus and hyoid advancement in the treatment of obstructive sleep apnea syndrome (OSAS).

Design  Prospective study of 20 consecutive patients with OSAS.

Setting  University medical center.

Patients and Interventions  Twenty OSAS patients with multilevel upper airway obstruction who refused continuous positive airway pressure treatment. All patients were evaluated before and 6 months after surgery by clinical history, the Epworth Sleepiness Scale, physical examination, fiberoptic nasopharyngoscopy combined with the Müller maneuver, cephalometric analysis, nocturnal polysomnography, and a second-night polysomnography with upper airway pressure recording during sleep. Surgery procedures were uvulopalatopharyngoplasty plus mandibular osteotomy with genioglossus and hyoid advancement. Surgical successful outcome was defined as an apnea-hypopnea index (AHI) lower than 20 plus subjective resolution of daytime symptoms.

Main Outcome Measure  Surgical success rate.

Results  Mean ± SD AHI decreased from 60.5 ± 16.5 to 44.6 ± 27 (P = .007), and CT90 (percentage of time with oxyhemoglobin saturation below 90%) decreased from 39.5% ± 26% to 25.1% ± 26.4% (P = .002). The overall surgical success rate was 35% but increased to 57% in patients with moderate OSAS (AHI, 41-60) and to 100% in mild OSAS (AHI, 21-40). In the group of severe OSAS, the success rate was 9%. Predictors of surgical outcome success were the AHI, CT90, stages 2 and 3-4 sleep percentages, and the cephalometric ANB angle (angle formed from the deepest point on the maxillary outer contour to the nasion to the deepest point on the outer mandibular contour).

Conclusion  Patients with mild and moderate OSAS and multilevel obstruction in the upper airway may benefit from uvulopalatopharyngoplasty plus genioglossus and hyoid advancement.


From the Services of Otorhinolaryngology (Drs Vilaseca and Morelló), Pneumology (Dr Montserrat), and Neurology (Drs Santamaría and Iranzo), University of Barcelona, Hospital Clínic, Barcelona, Spain.


RELATED ARTICLE

Archives of Otolaryngology–Head & Neck Surgery Reader's Choice: Continuing Medical Education
Arch Otolaryngol Head Neck Surg. 2002;128(4):465-466.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgical Treatment of Obstructive Sleep Apnea: Upper Airway and Maxillomandibular Surgery
Won et al.
Proc Am Thorac Soc 2008;5:193-199.
ABSTRACT | FULL TEXT  

Hypopharyngeal surgery in obstructive sleep apnea: an evidence-based medicine review.
Kezirian and Goldberg
Arch Otolaryngol Head Neck Surg 2006;132:206-213.
ABSTRACT | FULL TEXT  

Outcomes of Hyoid Suspension for the Treatment of Obstructive Sleep Apnea
Bowden et al.
Arch Otolaryngol Head Neck Surg 2005;131:440-445.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.